The combination of Ceftriaxone, Disodium edetate, and Sulbactam is an antibiotic used to treat various bacterial infections, including those of the respiratory, urinary, and soft tissues. Sulbactam protects Ceftriaxone from beta-lactamase enzymes, while Disodium edetate boosts its efficacy.

The combination of Ceftriaxone, Disodium edetate, and Sulbactam is used to treat a variety of serious bacterial infections, including respiratory, urinary tract, and intra-abdominal infections. It is also effective in managing sepsis and infections caused by beta-lactamase-producing bacteria. The combination enhances antibacterial activity, especially against resistant strains.

Ceftriaxone, Disodium edetate, and Sulbactam combination is administered intravenously (IV) or intramuscularly (IM). Healthcare providers adjust the dosage based on the infection type, severity, and patient factors. The drug is reconstituted with a suitable diluent, and the IV infusion is given over 30 minutes to 1 hour to reduce irritation.

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.

Common side effects of Ceftriaxone, Disodium edetate and Sulbactam:

• Pain or swelling at the injection site
• Diarrhoea
• Nausea or vomiting
• Rash
• Fever
• Headache

Serious side effects of Ceftriaxone, Disodium edetate and Sulbactam:

• Allergic reactions (e.g., difficulty breathing, swelling of face or throat)
• Severe diarrhoea (Clostridium difficile-associated diarrhoea)
• Liver or kidney dysfunction (e.g., jaundice, dark urine)
• Blood disorders (e.g., low white blood cell count, anaemia)
• Seizures (especially in patients with renal impairment)

• Hypersensitivity reactions: Be cautious in patients with a history of allergies to beta-lactam antibiotics, as severe reactions (e.g., anaphylaxis) can occur.
• Renal impairment: Adjust doses for patients with renal issues to avoid toxicity, especially the risk of seizures.
• Neonates: Avoid use in newborns, particularly those with high bilirubin levels, as Ceftriaxone can displace bilirubin, increasing the risk of bilirubin encephalopathy.
• GI disturbances: Watch for Clostridium difficile-associated diarrhoea, and discontinue the drug if severe diarrhoea develops.
• Calcium-containing solutions: Do not mix or infuse Ceftriaxone with calcium-containing solutions due to the risk of precipitation, especially in neonates.
• Blood disorders: Regularly monitor blood counts, as the combination can cause leucopenia, thrombocytopenia, or other blood abnormalities.

Use Ceftriaxone, Disodium edetate, and Sulbactam with caution in patients with renal impairment, as dose adjustments may be needed. Avoid its use in neonates with high bilirubin levels due to the risk of bilirubin encephalopathy. Monitor for signs of allergic reactions, GI disturbances, and blood disorders during treatment. Avoid concurrent use with calcium-containing solutions in neonates to prevent precipitation.

When using Ceftriaxone, Disodium edetate, and Sulbactam, follow the prescribed dosage and complete the full course of treatment, even if symptoms improve. Monitor for potential side effects like allergic reactions or gastrointestinal disturbances. Ensure dose adjustments for patients with renal impairment and avoid use in neonates with high bilirubin levels. Always inform your healthcare provider about any other medications you’re taking, especially calcium-containing products, to avoid adverse interactions.

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.